SYK
Stryker Corporation NYSE Listed Mar 17, 1980$294.25
Mkt Cap $112.7B
52w Low $289.91
3.8% of range
52w High $404.87
50d MA $339.59
200d MA $363.15
P/E (TTM)
34.7x
EV/EBITDA
23.0x
P/B
5.0x
Debt/Equity
0.7x
ROE
7.2%
P/FCF
31.4x
RSI (14)
—
ATR (14)
—
Beta
0.93
50d MA
$339.59
200d MA
$363.15
Avg Volume
2.1M
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.
1941 Stryker Way · Portage, MI 49002 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 30, 2026 | AMC | 2.98 | 2.60 | -12.8% | 315.13 | -0.6% | -6.5% | -7.7% | -6.3% | -7.2% | -6.6% | — |
| Jan 29, 2026 | AMC | 4.40 | 4.47 | +1.6% | 354.30 | +4.2% | +4.3% | +3.9% | +1.8% | +1.8% | +2.3% | — |
| Oct 30, 2025 | AMC | 3.13 | 3.19 | +1.9% | 368.98 | -1.4% | -3.5% | -2.9% | -1.7% | -3.1% | -4.1% | — |
| Jul 31, 2025 | AMC | 3.07 | 3.13 | +2.0% | 392.73 | -5.2% | -3.8% | -2.9% | -3.0% | -4.5% | -4.2% | — |
| May 1, 2025 | AMC | 2.71 | 2.84 | +4.8% | 373.99 | -0.0% | +1.1% | +2.0% | +0.9% | +2.7% | +2.3% | — |
| Jan 28, 2025 | AMC | 3.87 | 4.01 | +3.6% | 395.15 | -0.0% | -1.0% | -1.2% | -1.0% | -1.0% | -0.7% | — |
| Oct 29, 2024 | AMC | 2.77 | 2.87 | +3.6% | 359.01 | +1.9% | +1.2% | -0.8% | +2.3% | +2.2% | +3.0% | — |
| Jul 30, 2024 | AMC | 2.79 | 2.81 | +0.7% | 330.22 | +0.1% | -0.8% | +0.9% | +0.4% | -4.3% | -2.3% | — |
| Apr 30, 2024 | AMC | 2.35 | 2.50 | +6.4% | 336.50 | -0.9% | -2.5% | -2.9% | -2.4% | -3.3% | -1.3% | — |
| Jan 30, 2024 | AMC | 3.27 | 3.46 | +5.8% | 316.64 | +7.1% | +6.0% | +7.6% | +8.0% | +8.3% | +7.3% | — |
| Nov 2, 2023 | AMC | 2.44 | 2.46 | +0.8% | 278.23 | -1.4% | -0.7% | -0.5% | -1.2% | -1.2% | -2.7% | — |
| Aug 3, 2023 | AMC | 2.38 | 2.54 | +6.7% | 275.62 | +3.0% | +2.9% | +3.9% | +2.4% | +2.3% | +2.7% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 1 | Canaccord Genuity | Maintains | Buy → Buy | — | $315.13 | $313.34 | -0.6% | -6.5% | -7.7% | -6.3% | -7.2% | -6.6% |
| May 1 | JP Morgan | Maintains | Overweight → Overweight | — | $315.13 | $313.34 | -0.6% | -6.5% | -7.7% | -6.3% | -7.2% | -6.6% |
| May 1 | Needham | Maintains | Buy → Buy | — | $315.13 | $313.34 | -0.6% | -6.5% | -7.7% | -6.3% | -7.2% | -6.6% |
| May 1 | BTIG | Maintains | Buy → Buy | — | $315.13 | $313.34 | -0.6% | -6.5% | -7.7% | -6.3% | -7.2% | -6.6% |
| May 1 | Wells Fargo | Maintains | Overweight → Overweight | — | $315.13 | $313.34 | -0.6% | -6.5% | -7.7% | -6.3% | -7.2% | -6.6% |
| May 1 | Evercore ISI | Maintains | Outperform → Outperform | — | $315.13 | $313.34 | -0.6% | -6.5% | -7.7% | -6.3% | -7.2% | -6.6% |
| Apr 15 | Truist | Maintains | Hold → Hold | — | $345.88 | $346.71 | +0.2% | -1.3% | -2.2% | -0.7% | -2.2% | -5.4% |
| Apr 14 | BTIG | Maintains | Buy → Buy | — | $347.24 | $347.84 | +0.2% | -0.4% | -1.7% | -2.6% | -1.1% | -2.6% |
| Apr 9 | Goldman Sachs | Maintains | Neutral → Neutral | — | $340.01 | $338.16 | -0.5% | -0.3% | -0.3% | +2.1% | +1.7% | +0.4% |
| Apr 7 | Citigroup | Maintains | Buy → Buy | — | $332.30 | $330.25 | -0.6% | -0.1% | +2.3% | +2.1% | +2.1% | +4.5% |
| Apr 6 | Evercore ISI | Maintains | Outperform → Outperform | — | $331.54 | $330.91 | -0.2% | +0.2% | +0.2% | +2.6% | +2.3% | +2.3% |
| Mar 17 | UBS | Maintains | Neutral → Neutral | — | $349.56 | $350.51 | +0.3% | -0.1% | -1.1% | -2.8% | -4.0% | -4.9% |
| Feb 24 | UBS | Maintains | Neutral → Neutral | — | $384.73 | $384.27 | -0.1% | -0.9% | -0.2% | +0.3% | +0.7% | +0.6% |
| Jan 30 | BTIG | Maintains | Buy → Buy | — | $354.30 | $369.10 | +4.2% | +4.3% | +3.9% | +1.8% | +1.8% | +2.3% |
| Jan 30 | Needham | Maintains | Buy → Buy | — | $354.30 | $369.10 | +4.2% | +4.3% | +3.9% | +1.8% | +1.8% | +2.3% |
| Jan 9 | Bernstein | Maintains | Outperform → Outperform | — | $367.21 | $367.97 | +0.2% | +0.1% | -1.6% | -3.1% | -2.1% | -1.3% |
| Dec 19 | Citizens | Upgrade | Market Perform → Market Outperform | — | $353.11 | $354.80 | +0.5% | +0.6% | +1.0% | +0.5% | +0.5% | +0.3% |
| Dec 18 | Truist | Maintains | Hold → Hold | — | $352.58 | $353.84 | +0.4% | +0.2% | +0.7% | +1.1% | +0.6% | +0.6% |
| Dec 11 | Citigroup | Maintains | Buy → Buy | — | $353.80 | $355.47 | +0.5% | -0.2% | +0.1% | +0.4% | -0.6% | -0.3% |
| Nov 14 | Wells Fargo | Maintains | Overweight → Overweight | — | $373.42 | $371.82 | -0.4% | -3.0% | -3.6% | -3.7% | -2.5% | -3.5% |
| Nov 14 | Needham | Maintains | Buy → Buy | — | $373.42 | $371.82 | -0.4% | -3.0% | -3.6% | -3.7% | -2.5% | -3.5% |
| Nov 14 | BTIG | Maintains | Buy → Buy | — | $373.42 | $371.82 | -0.4% | -3.0% | -3.6% | -3.7% | -2.5% | -3.5% |
| Nov 14 | Truist | Maintains | Hold → Hold | — | $373.42 | $371.82 | -0.4% | -3.0% | -3.6% | -3.7% | -2.5% | -3.5% |
| Nov 3 | Truist | Maintains | Hold → Hold | — | $356.24 | $356.60 | +0.1% | +0.5% | +1.8% | +0.4% | -0.7% | -0.1% |
| Oct 31 | BTIG | Maintains | Buy → Buy | — | $368.98 | $363.70 | -1.4% | -3.5% | -2.9% | -1.7% | -3.1% | -4.1% |
| Oct 31 | Evercore ISI | Maintains | Outperform → Outperform | — | $368.98 | $363.70 | -1.4% | -3.5% | -2.9% | -1.7% | -3.1% | -4.1% |
| Oct 22 | Barclays | Maintains | Overweight → Overweight | — | $379.76 | $385.61 | +1.5% | +2.3% | +0.9% | +0.5% | +1.0% | -1.0% |
| Oct 15 | Truist | Maintains | Hold → Hold | — | $370.00 | $369.57 | -0.1% | -0.1% | -0.2% | +1.2% | +3.0% | +2.6% |
| Oct 13 | BTIG | Maintains | Buy → Buy | — | $364.60 | $363.96 | -0.2% | +0.1% | +1.5% | +1.4% | +1.3% | +2.7% |
| Oct 7 | Evercore ISI | Maintains | Outperform → Outperform | — | $366.28 | $367.09 | +0.2% | +0.8% | +2.5% | +1.1% | -0.5% | -0.4% |
| Aug 4 | Truist | Maintains | Hold → Hold | — | $377.79 | $378.86 | +0.3% | +1.0% | +0.8% | -0.8% | -0.4% | -0.1% |
| Aug 1 | Needham | Maintains | Buy → Buy | — | $392.73 | $372.32 | -5.2% | -3.8% | -2.9% | -3.0% | -4.5% | -4.2% |
| Aug 1 | Wells Fargo | Maintains | Overweight → Overweight | — | $392.73 | $372.32 | -5.2% | -3.8% | -2.9% | -3.0% | -4.5% | -4.2% |
| Jul 8 | Evercore ISI | Maintains | Outperform → Outperform | — | $392.51 | $390.00 | -0.6% | -0.8% | -0.1% | +0.6% | -0.8% | -0.3% |
| May 22 | Citigroup | Maintains | Buy → Buy | — | $379.75 | $378.14 | -0.4% | -0.4% | -0.8% | +1.1% | +0.2% | +0.7% |
| May 5 | Truist | Maintains | Hold → Hold | — | $378.22 | $377.85 | -0.1% | +0.8% | -0.2% | +1.5% | +1.1% | +0.7% |
| May 5 | JMP Securities | Maintains | Market Perform → Market Perform | — | $378.22 | $377.85 | -0.1% | +0.8% | -0.2% | +1.5% | +1.1% | +0.7% |
| May 2 | Evercore ISI | Maintains | Outperform → Outperform | — | $373.99 | $373.89 | -0.0% | +1.1% | +2.0% | +0.9% | +2.7% | +2.3% |
| May 2 | Roth MKM | Maintains | Buy → Buy | — | $373.99 | $373.89 | -0.0% | +1.1% | +2.0% | +0.9% | +2.7% | +2.3% |
| Mar 21 | Needham | Maintains | Buy → Buy | — | $374.22 | $371.33 | -0.8% | -0.8% | +0.0% | -0.4% | -1.7% | -1.8% |
| Feb 18 | JMP Securities | Maintains | Market Perform → Market Perform | — | $385.18 | $383.00 | -0.6% | +0.1% | +0.9% | +0.3% | -0.6% | +0.7% |
| Feb 10 | Barclays | Maintains | Overweight → Overweight | — | $391.40 | $392.79 | +0.4% | +0.3% | -0.2% | -1.5% | -0.8% | -1.6% |
| Jan 30 | Goldman Sachs | Maintains | Neutral → Neutral | — | $391.07 | $394.15 | +0.8% | -0.2% | +0.1% | +0.0% | +0.3% | +2.1% |
| Jan 30 | Truist | Maintains | Hold → Hold | — | $391.07 | $394.15 | +0.8% | -0.2% | +0.1% | +0.0% | +0.3% | +2.1% |
| Jan 29 | Canaccord Genuity | Maintains | Buy → Buy | — | $395.15 | $395.00 | -0.0% | -1.0% | -1.2% | -1.0% | -1.0% | -0.7% |
| Jan 29 | RBC Capital | Maintains | Outperform → Outperform | — | $395.15 | $395.00 | -0.0% | -1.0% | -1.2% | -1.0% | -1.0% | -0.7% |
| Jan 29 | Stifel | Maintains | Buy → Buy | — | $395.15 | $395.00 | -0.0% | -1.0% | -1.2% | -1.0% | -1.0% | -0.7% |
| Jan 29 | Wells Fargo | Maintains | Overweight → Overweight | — | $395.15 | $395.00 | -0.0% | -1.0% | -1.2% | -1.0% | -1.0% | -0.7% |
| Jan 29 | Needham | Maintains | Buy → Buy | — | $395.15 | $395.00 | -0.0% | -1.0% | -1.2% | -1.0% | -1.0% | -0.7% |
| Jan 29 | JP Morgan | Maintains | Overweight → Overweight | — | $395.15 | $395.00 | -0.0% | -1.0% | -1.2% | -1.0% | -1.0% | -0.7% |
No insider trades available.
8-K
Stryker Corporation -- 8-K Filing
Stryker Corporation reaffirmed its full-year 2026 guidance despite implementing organizational restructuring, signaling management confidence in underlying business performance and growth momentum.
Apr 30
8-K · 7.01
! Medium
Unknown — 8-K 7.01: Regulation FD Disclosure
Stryker will report Q1 FY2026 earnings April 30, 2026, providing detailed financial results and full-year guidance that investors should monitor for growth trajectory and margin performance.
Apr 9
8-K
Unknown — 8-K Filing
Palo Alto Networks' security incident appears contained to internal systems with no customer compromise, reducing litigation risk and protecting PANW's reputation and revenue relationships.
Mar 23
8-K
Unknown — 8-K Filing
Stryker disclosed a cybersecurity incident in this 8-K, creating uncertainty around operational disruption and potential financial impact that investors should monitor for earnings consequences.
Mar 12
8-K
Unknown — 8-K Filing
Stryker disclosed a significant cybersecurity incident in this 8-K, creating uncertainty around operational impact, financial costs, and potential liability exposure that investors should monitor closely.
Mar 11
Data updated apr 27, 2026 3:49am
· Source: massive.com